Please login to the form below

Not currently logged in
Email:
Password:

Relvar

This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs GSK's asthma drug Breo for adults only

FDA panel backs GSK's asthma drug Breo for adults only

The product is sold as Relvar in some markets and is a follow-up to GSK's blockbuster Seretide/Advair product and combines LABA vilanterol with the inhaled corticosteroid (ICS) fluticasone

Latest news

  • GSK replaces head of US operations GSK replaces head of US operations

    up Relvar/Breo (fluticasone furoate and vilanterol) - to get off to a flying start in the increasingly competitive respiratory sector.

  • GSK sees COPD future in triple therapy GSK sees COPD future in triple therapy

    combination Anoro (umeclidinium and vilanterol) and Advair follow-up Relvar/Breo (fluticasone furoate and vilanterol) - to get the division back on track.

  • GSK trial throws everything at COPD GSK trial throws everything at COPD

    All three drugs will be delivering via GSK's Ellipta inhaler, which is already used in the company's recently introduced dual therapies Anoro (umeclidinium and vilanterol) and Relvar/Breo (fluticasone

  • SMC: Celgene's Abraxane 'too expensive' for Scotland SMC: Celgene's Abraxane 'too expensive' for Scotland

    SMC: Celgene's Abraxane 'too expensive' for Scotland. But medicines watchdog backs Sovaldi, Invokana, Defitelio, Relvar Ellipta. ... Drugs that received positive opinions included Janssen's Invokana (canagliflozin) for type 2 diabetes, Jazz

  • GSK clear to launch COPD hope Anoro in Europe GSK clear to launch COPD hope Anoro in Europe

    GSK needs its new respiratory products - which also include Theravance-partnered combination LABA and steroid drug Breo/Relvar (vilanterol and fluticasone) - if it is to lessen the impact of emerging competition

More from news
Approximately 2 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PAN Unlimited

PAN Unlimited specialises in developing Influential Creativity - ideas that make people feel, behave and think differently (www.influentialcreativity.com) Influential Creativity...

Latest intelligence

blog-icon-webinar-storytelling.png
Webinar recording: The storytelling method that works for e-detailing
If you can involve healthcare professionals in a story, they will be more open to your arguments....
MORE MONEY FOR THE NHS – BUT IS THIS THE ANSWER?
Paul Mannu of Cello Health Insight says that politicians opening their pre-election cheque books can’t put the NHS where it needs to be – but pharma can play a major...
Medius Deal Watch
Pharma deals in February 2015
Pfizer and Valeant led the way during a respectable, if not record-breaking, month for mergers, acquisitions and collaborations...

Infographics